Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
>Underlying growth at 3.9%, high margin - Synlab reported € 682.4m in Q1 revenues, down 2.8% (+3.9% underlying growth). Adjusted EBITDA came in at € 123.1m and adjusted operating profit at € 64.8m.Adjusted net debt stood at € 1,249m (reported net debt € 1,285m) vs € 1,582m at the end of Q1 2023 (and € 1.3bn at end-2023). Reported financial leverage stands at 2.75x (vs 2.9x at end-2023).Management reiterated its 2024 guidance, namely 4% organic growth (around...
>Croissance underlying à 3,9% - Bon niveau de marge - Synlab publie un CA T1 à 682,4 M€, soit -2,8% (+3,9% underlying growth). L’EBITDA ajusté ressort à 123,1 M€ et le ROP ajusté, à 64,8 M€.La dette nette ajustée atteint 1 249 M€ (DN publiée 1 285 M€) vs 1 582 M€ fin T1 2023 (et 1 300 M€ fin 2023). Le levier financier publié ressort à 2,75x (vs 2,9x fin 2023).Le management réitère sa guidance 2024 ie. une croissance organique de 4% (env. 2 700 M€), une marge...
EQS-News: SYNLAB AG / Key word(s): Quarter Results SYNLAB delivers strong performance in Q1 2024 08.05.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. SYNLAB delivers strong performance in Q1 2024 Revenue at €682 million Strong underlying organic growth at 3.9% (Q1 2023: 10.0%); 5.2% adjusted for working days Adjusted EBITDA at €123 million (increased by 4% compared to Q1 2023) Strong Adjusted EBITDA margin at 18.0% (Q1 2023: 16.9%), at the upper end of the guided range for FY 2024 of 17-18% €8 million of SALIX savings ...
EQS-News: SYNLAB AG / Schlagwort(e): Quartalsergebnis SYNLAB erzielt starke Leistung im Q1 2024 08.05.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. SYNLAB erzielt starke Leistung im Q1 2024 Umsatzerlöse von 682 Mio. € Starkes zugrunde liegendes organisches Wachstum von 3,9 % (Q1 2023: 10,0 %) bzw. 5,2 % (arbeitstagebereinigt) Bereinigtes EBITDA von 123 Mio. € (Anstieg um 4 % gegenüber Q1 2023) Starke AEBITDA-Marge von 18,0 % (Q1 2023: 16,9 %) am oberen Ende der Prognose für das Geschäftsjahr 2024 von 17 - 18 % S...
EQS-News: SYNLAB AG / Key word(s): Statement SYNLAB Italy has restored operations after cyber-attack 30.04.2024 / 14:56 CET/CEST The issuer is solely responsible for the content of this announcement. SYNLAB Italy has restored operations after cyber-attack SYNLAB Italy has restored operations and will gradually resume all services for patients and customers. Due to a cyber-attack, SYNLAB had suspended operations in Italy as a precautionary measure. SYNLAB Group confirms no impact on operations in other countries. SYNLAB AG ("SYNLAB", FSE: SYAB) announces that SYNLA...
EQS-News: SYNLAB AG / Schlagwort(e): Stellungnahme SYNLAB Italien hat Betrieb nach Cyberangriff wieder aufgenommen 30.04.2024 / 14:56 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. SYNLAB Italien hat Betrieb nach Cyberangriff wieder aufgenommen SYNLAB Italien hat den Geschäftsbetrieb wieder aufgenommen und wird sukzessiv alle Dienstleistungen für Patienten und Kunden wieder zur Verfügung stellen. Aufgrund eines Cyberangriffs hatte SYNLAB den Betrieb in Italien als Vorsichtsmaßnahme weitestgehend ausgesetzt. SYNLAB Konzern bestät...
>2023 EBITDA margin: 16.6% (vs 16.5% at 9M) - This morning, Synlab reported its full-year results: FY 2023 sales came to € 2.64bn (-18% and +6.4% org. - cons: € 2,688m est.), adjusted EBITDA stood at € 438m (cons: € 462m est.), 16.6% of sales, EBIT at € 194.2m (cons: € 155m est.) and net profit was € 44m (cons: € 72m est.).FCF came to € 75m, meaning that net debt ended the year at € 1,341m (vs € 1,575m at end-2022).For 2024, Synlab is guiding on organic grow...
>Marge d’EBITDA 2023 : 16,6% (vs 16,5% à 9M) - Synlab publie, ce matin, ses résultats annuels : le CA 2203 atteint 2,64 Md€ (-18% et +6,4% org. - css : 2 688 M€e), l’EBITDA ajusté se monte à 438 M€ (css : 462 M€e), soit 16,6% du CA, l’EBIT à 194,2 M€ (css : 155 M€e) et le RN, ressort à 44 M€ (css : 72 M€e).Le FCFu atteint 75 M€, et de fait, l’endettement net finit l’exercice à 1 341 M€ (vs 1 575 M€ fin 2022). Pour 2024, Synlab guide sur une croissance organique ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.